REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today reported financial results and provided a business update for the three months ended December 31, 2025. Congenital Hyperinsulinism (HI)In December 2025, Rezolute reported topline results from sunRIZE, a Phase 3, multicenter, double-blind, randomized, placebo-controlled safety and efficacy study of ersodetug for the treatment of congenital HI. The study did not meet its primary or key secondary endpoints.The study demonstrated reductions from baseline in hypoglycemia events by self-monitored blood glucose at both ersodetug dose levels, but reductions were not statistically significant compared to...

Company delivers 100th consecutive quarter of topline growth Fourth quarter 2025 revenue grew 13% and recurring revenue grew 14% from the fourth quarter of 2024 Announces planned retirement of Chief Financial Officer and appointment of new Chief Financial Officer Announces increase to Share Repurchase Program  MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) — SPS Commerce, Inc. (NASDAQ: SPSC), the leading intelligent supply chain network, today announced financial results for the fourth quarter and year ended December 31, 2025. Financial Highlights Fourth Quarter 2025 Financial HighlightsRevenue was $192.7 million in the fourth quarter of 2025, compared to $170.9 million in the fourth quarter of 2024, reflecting 13% growth. Recurring revenue grew 14% from the fourth quarter of 2024. Net income was $25.8 million or $0.68 per diluted...

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results:  Q4 2025 Q4 2024 FY 2025 FY 2024Revenue (in millions) $44.6 $39.2 $160.0 $154.0Consumable revenue (in millions) $21.6 $18.8 $82.0 $70.3Instrument revenue (in millions) $17.3 $15.3 $53.8 $65.8Service and other revenue (in millions) $5.7 $5.1 $24.2 $17.9RevioTM system placements 21 23 61 97VegaTM system placements 42 7 140 7Annualized Revio pull-through per system ~$242,000 ~$240,000 ~$233,000 ~$252,000Ending cash, cash equivalents, and investments(in millions) $279.5 $389.9    Gross margin, operating expenses, net income (loss), and net income (loss) per share are reported on a GAAP and non-GAAP basis....

CLAYTON, Mo., Feb. 12, 2026 (GLOBE NEWSWIRE) — Perimeter Solutions (NYSE: PRM) (“Perimeter” or the “Company”), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, announced today it will release its financial results for the fourth quarter and year end 2025 on Thursday, February 26, 2026, before the market opens. The Company will host a conference call to discuss these results at 8:30 a.m. ET on the same day. The presentation will be led by CEO Haitham Khouri, CFO Kyle Sable, and Head of Investor Relations Seth Barker. The live webcast of the call can be accessed through Perimeter’s investor relations website at https://ir.perimeter-solutions.com/ and as follows: When: Thursday, February 26, 2026, at 8:30 AM (ET) Dial-in Number: 877-407-9764...

MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the fourth quarter and full year of 2025. Recent HighlightsTotal revenue for the fourth quarter 2025 was $16.0 million, an increase of 4% over the prior year quarter U.S. revenue for the fourth quarter of 2025 was $14.9 million, an increase of 4% over the prior year quarter Total revenue for 2025 was $56.7 million, an increase of 10% over the prior year Active implanting centers in the U.S. grew to 252 in 2025, as compared to 223 in the prior year Initiated the BENEFIT-HF trial with first enrollments expected...

SANTA CLARA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its fourth quarter and full year ended December 31, 2025. Financial Highlights of Fourth Quarter 2025● Record quarterly total revenues of $62.4 million, up 25% over last year’s comparable quarter● GAAP gross margin of 73% and non-GAAP gross margin of 77%● GAAP operating margin of 6% and non-GAAP operating margin of 24%● GAAP diluted loss per share (LPS) of $(0.00)and non-GAAP diluted earnings per share (EPS) of $0.30   Financial Highlights of Full Year 2025● Record full year total revenues of $219.0 million, up 22% over last year● GAAP gross margin of 72% and non-GAAP gross margin...

Revenue $7.01 billion, down 2 percent year over year GAAP gross margin 49.0 percent and non-GAAP gross margin 49.1 percent GAAP EPS $2.54 and non-GAAP EPS $2.38, up 75 percent and flat year over year, respectively Semiconductor Systems achieved record DRAM revenue Applied Global Services delivered record services and spares revenueSANTA CLARA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc. (NASDAQ : AMAT) today reported results for its first quarter ended Jan. 25, 2026. First Quarter Results Applied generated revenue of $7.01 billion. On a GAAP basis, the company reported gross margin of 49.0 percent, operating income of $1.83 billion or 26.1 percent of net revenue, and earnings per share (EPS) of $2.54. On a non-GAAP basis, the company reported gross margin of 49.1 percent, operating income of $2.11 billion...

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the fourth quarter and year ended December 31, 2025. David Clare, President and CEO of Trisura, stated, “2025 was characterized by stability, focused growth and consistent execution, with 17.8% growth in book value supported by an 84.9% combined ratio and 17.3% increase in investment income. We ended the year strong, with fourth quarter Operating net income of $36.6 million, or $0.75 per share, contributing to record annual Operating net income of $138.4 million for the year. The strength of our opportunity was highlighted by an 11.8% increase in Net insurance revenue, underpinned by momentum in Primary lines which grew 15.4% in the quarter and 20.4%...

VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights and Recent Business UpdatesTotal revenue of $17.6 million, compared to $18.4 million in the fourth quarter of 2024, reflecting the lingering impact of reimbursement headwinds throughout 2025. Gross profit margin of 81.2%, reflecting product mix and inventory-related adjustments. Net use of cash improved for the second consecutive quarter to approximately $5.1 million, compared to $6.2 million in the third quarter, underscoring continued progress in cash efficiency. Operating expenses...

Adjusted EBITDA up 15% to $18.5M; Gross Margin expands 210 basis points to 12.8% Net Income increased to $9.4M, or $0.18 per share, compared to $7.1M, or $0.14 per share, in Q2 FY25 Strengthened balance sheet, ending quarter with $74.1M in working capital PLANTATION, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor, logistics provider, and omnichannel fulfillment partner to the entertainment and pop culture collectibles industry, supplying more than 340,000 unique SKUs across music, video, video games, licensed merchandise, and exclusive collectibles to over 35,000 retail and e-commerce storefronts, reported its financial and operational results for its fiscal second quarter ended December 31, 2025. Second Quarter FY 2026 HighlightsSustained Profitability...